Ryanodex 250 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FZ3AD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,606
Award facts
- Contract value 100% obligated
- $9,606.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $9,606.42 by the Defense Logistics Agency on January 12, 2026, for the supply of Ryanodex 250 mg vials. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance will be completed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of February 3, 2026. This delivery order is executed under Cencora's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
Ryanodex (dantrolene sodium) is a critical medication used in the treatment of malignant hyperthermia and exertional heat stroke, conditions requiring immediate pharmaceutical intervention in military medical settings. The DLA, functioning as the primary logistics provider for the Department of Defense, procures essential pharmaceutical products through its Troop Support Medical division to maintain inventory for military treatment facilities and combat support hospitals worldwide. AmerisourceBergen's extensive pharmaceutical distribution network and established relationship with DLA, evidenced by its substantial IDC vehicle, positions it as a key supplier for federal medical procurement needs across the military healthcare system.
Quick answers
Who was awarded contract SPE2DR26FZ3AD?
SPE2DR26FZ3AD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FZ3AD worth?
The government has obligated $9,606 on SPE2DR26FZ3AD.
Is contract SPE2DR26FZ3AD an order under another contract?
Yes. SPE2DR26FZ3AD is a delivery order under SPE2DR25D1120, an indefinite delivery contract.
Was contract SPE2DR26FZ3AD competed?
The extent of competition for SPE2DR26FZ3AD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award